No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aniline Compounds / therapeutic use*
-
Antineoplastic Agents / therapeutic use*
-
Benzamides
-
Cell Proliferation / drug effects*
-
Drug Synergism
-
Fusion Proteins, bcr-abl / antagonists & inhibitors
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
-
Nitriles / therapeutic use*
-
Piperazines / therapeutic use*
-
Proto-Oncogene Proteins c-abl / antagonists & inhibitors
-
Pyrimidines / therapeutic use*
-
Quinolines / therapeutic use*
-
Tumor Cells, Cultured
-
src-Family Kinases / antagonists & inhibitors
Substances
-
Aniline Compounds
-
Antineoplastic Agents
-
Benzamides
-
Nitriles
-
Piperazines
-
Pyrimidines
-
Quinolines
-
bosutinib
-
Imatinib Mesylate
-
Fusion Proteins, bcr-abl
-
Proto-Oncogene Proteins c-abl
-
src-Family Kinases